| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Shoulder Innovations, Inc.$22.74
-0.45 (-1.94%)
F 16Pipeline Score MedTech · Clinical
Market Cap
302.78 M
EPS
-2.15
P/E Ratio
-
Value Trade
1.02 M
SEC Financials
Q1 2026Dilution Risk
Revenue
16.71 M
R&D Expenses
3.75 M
Operating CF
-12.36 M
Total Assets
160.36 M
Total Liabilities
27.34 M
Equity
133.02 M
D/E Ratio
12,345
-5.5 %
Week
4.58 %
1 Month
9.45 %
3 Month
6.34 %
6 Month
-6.41 %
5 Year
-6.41 %
All Time
Cash Data
Cash Position
108.54 M
Monthly Burn
4.12 M
Runway
23.9 mo
Burn Trend
SEC Filing
May 13, 2026
Overview
Volume
79.17 K
52 Week Range
10.92 - 17.94
% held by Insiders
46.14 %
% held by Institutions
36.33 %
Enterprise Value
209.25 M
Total Shares
20.73 M
Short %
1.95 %
Float Shares
10.72 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Shoulder Innovations, Inc.
1Total events
0Upcoming
0Tier-1 (high impact)
2026 – 2026Coverage
Event history 1
TBD
▲Debt Royalty FinancingCorporate
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
F16
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 12%
Micro Cap (rank 804 of 913)
Percentile RankShoulder Innovations, Inc. has significant pipeline risk (16/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SI
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SI Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SI▼ -1.9%today
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
Shoulder Innovations, Inc. will present at the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. The company specializes in shoulder surgical care and offers advanced implant systems for shoulder arthroplasty. A live webcast of the presentation will be available on their website.
Read more →SIShoulder Innovations to Report Second Quarter 2026 Financial Results on August 6, 2026
Shoulder Innovations, Inc. will report its financial results for Q2 2026 on August 6, 2026. The company, focused on shoulder surgical care, will host a conference call at 4:30 p.m. ET to discuss these results. Interested parties can access the call via phone or through a webcast on their website.
Read more →SI▼ -7.5%on this news
Shoulder Innovations Announces Closing of up to $50 Million Credit Facility
Shoulder Innovations has successfully closed two credit facilities totaling up to $50 million with Stifel Venture Banking. This includes a $15 million term loan to refinance existing debt and a $30 million line of credit. The new terms significantly improve the company's financial structure and provide additional working capital to support its growth in the shoulder surgical care market.
Read more →SIShoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Shoulder Innovations, Inc. has announced its participation in the Goldman Sachs 47th Annual Global Healthcare Conference scheduled for June 9, 2026. The company is focused on transforming the shoulder surgical care market with advanced implant systems. Their ecosystem aims to enhance preoperative planning and procedural efficiency, addressing challenges in shoulder surgical care.
Read more →SIShoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
Shoulder Innovations reported a strong financial performance for Q1 2026, with net revenue increasing by 65% to $16.7 million compared to the previous year. The company also raised its full year revenue guidance to between $65 million and $68 million, indicating robust growth prospects. However, the company faced increased operating losses and higher expenses in both selling and R&D.
Read more →SIShoulder Innovations Launches WISE – Women in Shoulder Excellence
Shoulder Innovations has launched the WISE program, aimed at fostering mentorship among women in shoulder surgery. The initiative focuses on creating meaningful mentor-mentee relationships to enhance professional development and leadership skills. Participants can engage in webinars and in-person meetings to expand their networks and gain insights from experienced professionals.
Read more →SIShoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem
Shoulder Innovations has officially launched the InSet I-135RFX Humeral Stem after a successful limited market release and FDA clearance for additional fracture indications. This product expands their offerings in shoulder arthroplasty, allowing use in all primary, revision, and fracture procedures. The launch signifies a milestone for the company and showcases their dedication to improving surgical care.
Read more →SIShoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026
Shoulder Innovations, Inc. will announce its financial results for Q1 2026 on May 13, 2026. The company is focused on improving shoulder surgical care and will host a conference call to discuss the results. Interested parties can access the call through provided contact details.
Read more →SIInSet® Interview with Dr. Veronica Diaz
In an interview, Dr. Veronica Diaz discusses her journey as an orthopedic surgeon and her experiences with the InSet® system from Shoulder Innovations. She emphasizes the evolution of shoulder surgery and the advantages of the InSet® glenoid technology, which offers better outcomes for patients. Dr. Diaz expresses her enthusiasm for the company's commitment to innovation and improving surgical results.
Read more →SIInSet® Interview with Dr. Michael Cushing
In an interview, Dr. Michael Cushing, an orthopedic surgeon, discusses his experiences with the InSet® system from Shoulder Innovations. He highlights the system's ease of use, positive patient outcomes, and the advancements in shoulder surgery since he began his practice. Dr. Cushing emphasizes the importance of surgeon feedback in driving innovation and expresses confidence in the stability and effectiveness of the InSet® glenoid.
Read more →SIShoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Shoulder Innovations, Inc. reported significant financial growth for Q4 and the full year 2025, with net revenues reaching $14.4 million in Q4 and $47.3 million for the year, marking increases of 65% and 50% respectively. The company also initiated guidance for 2026, projecting revenues between $62 million and $65 million. Key developments included the release of new implant systems and a strategic partnership to enhance their product offerings.
Read more →SIShoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-Year Grand Rapids, MI
Shoulder Innovations, Inc. (NYSE: SI) reported strong financial results for the fourth quarter and full year of 2025, with fourth-quarter net revenue soaring 65% year-over-year to $14.4 million. The company also experienced a 50% increase in full-year revenue, reaching $47.3 million. Looking ahead, management projects a net revenue forecast of $62 million to $65 million for 2026, indicating continued growth. However, the company recorded a higher operating loss and net loss in Q4 2025 compared to the previous year, primarily due to increased expenses related to operations and public company costs.
Read more →SIShoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors
Shoulder Innovations has appointed Drew Hykes to its Board of Directors, effective February 26, 2026. Hykes, a seasoned medical device executive, is expected to leverage his extensive experience to support the company's growth in the shoulder surgical care market. His appointment follows Geoff Pardo's resignation from the Board, who expressed confidence in the company's future.
Read more →SIShoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference
Shoulder Innovations, Inc. will present at the Canaccord Genuity 2026 Musculoskeletal Conference on March 3, 2026. The company specializes in advanced implant systems for shoulder surgeries and aims to improve surgical care through innovative technologies. A live stream of the presentation will be available on their website.
Read more →SI▲ +11.2%on this newsshared move
Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Shoulder Innovations, Inc. will announce its financial results for Q4 and the full year of 2025 on March 10, 2026. The company aims to enhance shoulder surgical care through advanced implant systems and a comprehensive ecosystem. A conference call will follow the results announcement for further discussion.
Read more →SIShoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Shoulder Innovations, Inc. will participate in the BTIG 13th Annual MedTech Conference on February 10-11, 2026. The company aims to transform shoulder surgical care with its advanced implant systems. Their ecosystem focuses on improving preoperative planning and procedural efficiency, addressing challenges in the shoulder surgical market.
Read more →SI▼ -5.2%on this newsshared move
Shoulder Innovations to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Shoulder Innovations, Inc. will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 10-11, 2026. The company focuses on transforming shoulder surgical care with advanced implant systems and a comprehensive ecosystem designed to enhance surgical efficiency and outcomes. This participation highlights their commitment to innovation in the medical technology sector.
Read more →SIShoulder Innovations Named One of BONEZONE’s Top 10 Orthopedic Companies to Watch in 2026
Shoulder Innovations has been recognized as one of BONEZONE's Top 10 Orthopedic Companies to Watch in 2026. This acknowledgment highlights the company's rapid growth and innovative approach to shoulder replacement. With an expected revenue of $45 to $46 million and a focus on efficiency in ambulatory surgical centers, the company is well-positioned for future success. Additionally, their partnership to develop a portable robotic solution further underscores their commitment to innovation.
Read more →SIShoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty
Shoulder Innovations has announced a strategic partnership with Interventional Systems to develop a micro-robotic platform aimed at enhancing shoulder arthroplasty procedures. This collaboration seeks to improve surgical accuracy and efficiency, particularly in ambulatory surgery centers. The portable robotic solution is designed to address existing challenges in robotic surgery, promising better outcomes for patients and surgeons alike.
Read more →SIShoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty Partnership will Expand Shoulder Innovations' Disruptive Ecosystem with Advanced Enabling Technology
Shoulder Innovations, Inc. has announced a strategic partnership with Interventional Systems (INS) to develop a robotic platform aimed at improving shoulder arthroplasty procedures. This new micro-robotic solution will integrate with Shoulder Innovations' existing ProVoyance platform, enhancing surgical precision and efficiency. The partnership addresses several operational challenges in robotic surgery, including costs and ease of implementation, potentially benefiting both surgeons and patients. The companies are optimistic about the market impact of their innovative collaboration.
Read more →SIShoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference
Shoulder Innovations, Inc. announced its participation in the Piper Sandler 37th Annual Healthcare Conference. Management will engage in a fireside chat on December 3, 2025, to discuss the company's advancements in shoulder surgical care. The event aims to highlight their innovative implant systems and overall ecosystem designed to improve surgical outcomes.
Read more →SIShoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
Shoulder Innovations reported a strong third quarter for 2025, with revenues reaching $11.8 million, a 58% increase year-over-year. The company also expanded its product line and received FDA clearance for new indications. Despite these successes, it faced increased operating and net losses due to rising expenses. The full-year revenue guidance has been raised to $45-$46 million.
Read more →SIShoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance Grand Rapids, MI
Shoulder Innovations reported its third quarter 2025 financial results, achieving a revenue of $11.8 million which represents a 58% increase year-over-year. The company also expanded its product offerings and received FDA clearance for certain fracture indications. Despite these positive developments, Shoulder Innovations faced increased operating expenses, contributing to a higher operating loss of $7.6 million. The outlook for full-year 2025 revenue has been raised to between $45 million and $46 million.
Read more →SIShoulder Innovations to Participate in the Jefferies Global Healthcare Conference
Shoulder Innovations, Inc. will present at the Jefferies Global Healthcare Conference on November 18, 2025. CEO Rob Ball is scheduled to speak at 8:30 a.m. GMT. The company specializes in advanced implant systems for shoulder arthroplasty and aims to improve surgical care efficiency and outcomes.
Read more →SIShoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025
Shoulder Innovations, Inc. will announce its third quarter 2025 financial results on November 11, 2025, after market close. A conference call will follow at 4:30 p.m. ET to discuss these results. The company aims to improve shoulder surgical care through advanced implant systems and a comprehensive care ecosystem.
Read more →SIShoulder Innovations Announces Full Commercial Launch of the InSet<sup>®</sup> 70 Humeral Stem
Shoulder Innovations has announced the full commercial launch of the InSet® 70 Humeral Stem, expanding its I-Series product line. This new implant is designed for both anatomic and reverse shoulder arthroplasty, addressing various clinical needs. The InSet® 70 aims to enhance patient outcomes and provide value to surgeons with its innovative design. The launch is ahead of schedule, showcasing the company's commitment to improving shoulder surgical care.
Read more →SI▼ -5.8%on this news· ran to -20% by day 1
Shoulder Innovations Reports Second Quarter 2025 Financial Results
Shoulder Innovations, Inc. reported strong financial results for Q2 2025, with a 33% increase in net revenue to $11.0 million and a gross margin of 76.2%. The company sold 1,503 implant systems, marking a 34% year-over-year growth. Additionally, it successfully completed a $40 million convertible notes financing and raised $75 million through its IPO. CEO Rob Ball expressed optimism about the company's growth and market adoption of its products.
Read more →SI▼ -5.8%on this news· ran to -20% by day 1shared move
Shoulder Innovations Reports Second Quarter 2025 Financial Results Company to Participate in a Fireside Chat at the Morgan Stanley 23 rd Annual Global Healthcare Conference Today at 8 30 a.m. ET Grand Rapids, MI
Shoulder Innovations, Inc. reported a strong second quarter for 2025, with a 33% year-over-year increase in net revenue, reaching $11.0 million. The company has also successfully completed a $40 million convertible notes financing and an initial public offering that raised $75 million. Despite these successes, the company experienced a significant increase in net loss, which rose to $19.2 million compared to the prior year. Management attributes the new financial strategies and market adoption to ongoing growth in their advanced implant systems.
Read more →SIHonoring Excellence: Newsweek-Recognized Shoulder Surgeons Working with Shoulder Innovations
Shoulder Innovations proudly announces that many of its Surgeon Advisory Board members have been recognized in Newsweek's 'America's Leading Doctors 2025 – Shoulder Surgery' list. This acknowledgment underscores their commitment to excellence in patient care and innovation in shoulder surgery. The company expresses gratitude for their contributions to advancing shoulder care across the nation.
Read more →SIShoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025
Shoulder Innovations, Inc. will release its second quarter 2025 financial results on September 9, 2025, before market open. On the same day, the management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The event will provide insights into the company's performance and future strategies.
Read more →SICEO Spotlight – Rob Ball Interviewed on NYSE TV
Rob Ball, CEO of Shoulder Innovations, was featured on NYSE TV following the company's successful IPO. He discussed the company's focus on shoulder arthroplasty, highlighting innovations such as the InSet® glenoid technology and efficient surgical instrumentation. Ball emphasized the importance of implant longevity, patient outcomes, and the shift towards outpatient procedures, showcasing SI's commitment to reducing surgical complexity and costs.
Read more →SIShoulder Innovations is Reaching Further<sup>™</sup> Following IPO
Shoulder Innovations has successfully completed its initial public offering (IPO), marking a significant milestone in its journey. The company emphasizes its commitment to advancing shoulder care and innovation in orthopedics through its 'Reaching Further™' initiative. This public listing is expected to enhance its impact and accelerate innovation, ultimately benefiting more patients.
Read more →SIShoulder Innovations Announces Pricing of Initial Public Offering
Shoulder Innovations, Inc. has announced the pricing of its initial public offering, offering 5 million shares at $15.00 each. The company has also granted underwriters a 30-day option to purchase an additional 750,000 shares. The IPO is expected to raise $75 million, with trading commencing on the NYSE under the ticker 'SI' on July 31, 2025.
Read more →SIShoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing
Shoulder Innovations has successfully closed a $40 million convertible notes financing led by Fidelity Management & Research Company. The funds will primarily support the commercialization of their advanced implant systems for shoulder arthroplasty and further product development. The company's innovative InSet® Glenoid technology aims to enhance surgical outcomes and procedural efficiency.
Read more →SIInterview With Dr. David Adkison
Dr. David Adkison, an orthopedic surgeon, shares his journey and experiences with InSet® Systems from Shoulder Innovations. He highlights the unique aspects of shoulder surgery and the significant improvements in patient outcomes since using the InSet® implants. Adkison emphasizes the logical design and effectiveness of the technology, expressing enthusiasm for its impact on his practice and patient recovery.
Read more →SIInterview With Dr. Patrick Hayes
In an interview, Dr. Patrick Hayes discusses his extensive background in orthopedics and his positive experiences using the InSet® Systems from Shoulder Innovations. He highlights the system's impact on patient outcomes, including pain relief and improved mobility. Dr. Hayes also appreciates the innovative design that simplifies surgery and enhances the reliability of shoulder replacements.
Read more →SIInterview With Dr. Kenneth Kearns
In an interview, Dr. Kenneth Kearns discusses his journey in orthopedics and his experiences with the InSet® Systems from Shoulder Innovations. He highlights the positive feedback from patients regarding their outcomes and the efficiency of the system in surgeries. Dr. Kearns emphasizes the versatility of the InSet® glenoid, which allows him to provide patients with fewer restrictions post-operation, leading to high satisfaction rates.
Read more →SIInterview With Dr. Fotios Tjoumakaris
In an interview, Dr. Fotios Tjoumakaris discusses his journey to orthopedics and the impact of the InSet® Shoulder System on his practice. He highlights the system's reliable glenoid fixation and its benefits for younger patients. Dr. Tjoumakaris also shares positive feedback from patients and the advantages of using ProVoyance surgical planning software.
Read more →SIDoes The InSet<sup>®</sup> Reverse Shoulder Behave More Like An Anatomic Total Shoulder Arthroplasty? | Dr. Peter Johnston
Shoulder Innovations has announced the closing of a credit facility worth up to $50 million. The company will also participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Additionally, they reported positive financial results for the first quarter of 2026, raising their outlook for the full year.
Read more →SIDoes the InSet<sup>®</sup> Reverse Shoulder Behave More Like an Anatomic Total Shoulder Arthroplasty? | Dr. Shariff K. Bishai
Shoulder Innovations has announced the closing of a credit facility of up to $50 million. The company will also participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Additionally, they reported positive financial results for the first quarter of 2026 and raised their outlook for the full year.
Read more →SIShoulder Innovations Announces Closing of $40 Million Series E Equity Financing
Shoulder Innovations has successfully closed a $40 million Series E equity financing round, led by U.S. Venture Partners. The funds will be used to advance the commercialization of their InSet® Total Shoulder and Reverse Shoulder Arthroplasty Systems and support new product development. The company aims to enhance patient outcomes and strengthen its market position in shoulder arthroplasty.
Read more →SIShoulder Innovations Launches Newly Redesigned Website
Shoulder Innovations has launched a newly redesigned website aimed at enhancing user experience for surgeons and patients. The site features streamlined navigation and easy access to resources related to their InSet® shoulder replacement technologies. This initiative aligns with the company's mission to improve shoulder arthroplasty and patient care through innovative solutions.
Read more →SIIn My Experience… Maximizing Outcomes After Shoulder Replacement Using Innovative Technology
Dr. Christopher Chuinard discusses advancements in shoulder replacement surgery, emphasizing innovative arthroplasty systems. The article highlights the importance of cutting-edge design and engineering in achieving long-term success and enhancing patient functionality. These insights aim to improve outcomes for individuals undergoing shoulder replacement procedures.
Read more →SIInterview with Dr. Walter Stanwood
In an interview, Dr. Walter Stanwood discusses his experiences with the InSet® Shoulder System from Shoulder Innovations. He emphasizes the system's advantages, including reduced patient pain, improved surgical efficiency, and the preservation of native bone during revisions. Dr. Stanwood also praises the company's innovative culture and responsive support for surgeons, highlighting the positive impact on patient outcomes.
Read more →SIIn the News – Reverse Shoulder Replacement Can Help With Healing and Recovery
Cincinnati Local 12 News highlighted a reverse shoulder replacement by Dr. Brandon Kohrs at Orthocincy. Patient Bill Walker, who suffered from shoulder pain, successfully returned to his hobbies post-surgery and expressed regret for not having the procedure earlier. The article emphasizes the positive impact of the surgery on patient recovery.
Read more →SIInterview with Dr. Eitan Kohan
In an interview, Dr. Eitan Kohan discusses his journey in orthopedics and the benefits of using the InSet® Shoulder System. He highlights its straightforward instrumentation, robust fixation, and advantages for both anatomic and reverse shoulder replacements. Dr. Kohan emphasizes the importance of thorough surgical planning using ProVoyance software, which aids in optimal implant placement. He praises the overall quality and support provided by Shoulder Innovations.
Read more →SIInterview with Dr. Matthew Pifer
In an interview, Dr. Matthew Pifer discusses his experience as an orthopedic surgeon specializing in shoulder procedures. He highlights the benefits of using the InSet® Shoulder System, which provides improved stability and reduces failure rates. Additionally, he emphasizes the importance of preoperative planning technology in enhancing surgical outcomes.
Read more →SIShoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants
Shoulder Innovations has announced the granting of nine new patents by the USPTO, enhancing its intellectual property portfolio in shoulder replacement technology. These patents cover innovative methods such as single-step glenoid preparation and porous coated convertible glenoids. The CEO emphasized the significance of these patents in advancing surgical techniques and improving patient outcomes. The company has a strong history of innovation in shoulder arthroplasty.
Read more →SIInterview with Dr. Kyle Shepperson
Dr. Kyle Shepperson, an orthopedic surgeon, shares insights on his experience with the InSet® Shoulder System from Shoulder Innovations. He highlights the system's advantages in glenoid fixation, surgical efficiency, and patient outcomes. Dr. Shepperson emphasizes the importance of the ProVoyance software for pre-surgical planning and expresses satisfaction with the system's performance in his practice.
Read more →SIShoulder Innovations Unveils New Humeral Preoperative Planning Feature with ProVoyance Shoulder
Shoulder Innovations has launched a new humeral preoperative planning feature for its ProVoyance Shoulder Software, which has received FDA clearance. This addition allows surgeons to plan with precision using the InSet® humeral stems, enhancing surgical outcomes. The platform utilizes advanced AI and ML to create accurate 3D reconstructions of shoulder anatomy, significantly improving the planning process.
Read more →SIIn the News – Dr. Kohrs Reverse Total Shoulder Arthroplasty
Dr. Brandon Kohrs of Orthocincy discussed Reverse Shoulder Replacement on Cincinnati Local 12 News. This procedure is suitable for patients suffering from severe shoulder pain, advanced arthritis, or irreparable rotator cuff injuries. The surgery involves reversing the ball and socket components of the shoulder joint to enhance stability and mobility. While it offers significant benefits, risks include infection and complications during healing.
Read more →SIShoulder Innovations Launches InSet<sup>®</sup> 95 Humeral Stem
Shoulder Innovations has launched the InSet® 95 Humeral Stem, designed to improve surgical outcomes for patients with poor bone quality. This new implant features a unique 2-fin design for enhanced stability and precise alignment. It also offers robust fixation capabilities and is convertible to Reverse Shoulder Arthroplasty, making it versatile for surgeons. The product aims to enhance patient recovery and quality of life.
Read more →SIInterview with Dr. Diego Villacis
In an interview, Dr. Diego Villacis discusses his journey to orthopedic surgery and his experiences with the InSet® Shoulder System. He highlights the system's benefits, including improved stability and longevity of implants, and its ease of use in surgeries. Dr. Villacis emphasizes the positive feedback from both patients and surgical staff, suggesting that the InSet® system could revolutionize shoulder surgery practices.
Read more →SIDr. Mark Schrumpf Stemless Shoulder Replacement from 2024 AAOS OrthoDome™
Shoulder Innovations has announced the closing of a credit facility worth up to $50 million. The company is set to participate in the Goldman Sachs 47th Annual Global Healthcare Conference, which could boost its market presence. Additionally, Shoulder Innovations reported positive financial results for the first quarter of 2026 and raised its full-year outlook.
Read more →SIInterview with Dr. Marion “Moose” Herring
Dr. Marion 'Moose' Herring discusses his journey in orthopedics, focusing on shoulder surgery and the use of InSet® Systems. He emphasizes the advantages of the InSet® Reverse system, including its design and efficiency in the operating room. Herring highlights the importance of collaboration among surgeons and the positive impact of the InSet® system on patient care.
Read more →SIInterview with Dr. Nathan Everding
Dr. Nathan Everding, an orthopedic surgeon, shares insights from his career and his experiences with the InSet® Shoulder System. He highlights the system's unique glenoid concept, versatility, and benefits for younger patients. The transition to a streamlined tray system has improved operating room efficiency and reduced clutter. Overall, Dr. Everding is optimistic about the future of shoulder arthroplasty.
Read more →SIInterview with Dr. David Fehnel
Dr. David Fehnel, an orthopedic surgeon, shares insights on his journey in shoulder surgery and the impact of the InSet® Shoulder System from Shoulder Innovations. He emphasizes the system's efficiency, simplicity, and the collaborative environment fostered by the company. Dr. Fehnel highlights the advancements in shoulder arthroplasty and expresses excitement for future innovations.
Read more →SIInterview with Dr. Brad Brautigan
Dr. Brad Brautigan discusses his journey in orthopedics and the impact of the InSet® System from Shoulder Innovations. He emphasizes the system's innovative design, cost efficiency, and clinical effectiveness, particularly in outpatient settings. The interview highlights the importance of understanding surgical costs and the potential for improved profit margins in ambulatory surgery centers.
Read more →SIRob Ball Named a 2023 Crain’s Newsmaker of the Year
Rob Ball, CEO of Shoulder Innovations Inc., has been honored as a 2023 Crain's Newsmaker of the Year. His leadership has driven the company to achieve notable financial successes, including a $45 million debt offering and a $42 million Series D equity financing. These funds are aimed at accelerating the commercialization of their orthopedic shoulder implant products.
Read more →SIInterview with Dr. Corey Solman
In an interview, Dr. Corey Solman discusses his journey as an orthopedic surgeon and his specialization in shoulder surgery. He highlights his experiences with InSet® Systems from Shoulder Innovations, emphasizing the technology's benefits in treating glenoid deformities and improving surgical outcomes. Dr. Solman shares insights on the importance of understanding shoulder anatomy for successful surgeries.
Read more →SIBONEZONE: It’s Time to Tap into the Growth Potential of Total Shoulders
The article discusses the transformative phase of shoulder replacement surgery, highlighting advancements in implant technology and surgical techniques. The market for shoulder arthroplasty is growing, with significant sales increases noted. Innovations like the InSet System aim to improve fixation and reduce complications, while the popularity of reverse shoulder replacements continues to rise. The future of shoulder surgery looks promising with ongoing advancements.
Read more →SIDr. Chris Chuinard Reverse Shoulder Replacement Surgery Video
Shoulder Innovations has announced the closing of a credit facility worth up to $50 million. The company will also participate in the Goldman Sachs 47th Annual Global Healthcare Conference. Additionally, they reported positive financial results for the first quarter of 2026 and raised their outlook for the full year.
Read more →SIShoulder Innovations Announces Placement of New CFO and New VP of Commercial Development
Shoulder Innovations Inc. has appointed Jeff Points as CFO and Jon Osborne as VP of Commercial Development. These hires aim to strengthen the company's financial management and commercial strategy, respectively. With significant financial resources secured, the company is poised for growth in the shoulder replacement market. Both executives bring extensive experience to support the company's strategic objectives.
Read more →SIInterview with Dr. Nathan Orvets
Dr. Nathan Orvets, an orthopedic surgeon, discusses his journey in healthcare and his specialization in shoulder surgery. He emphasizes the advantages of the InSet® Shoulder System, particularly its stability and versatility for various patient demographics. The interview highlights the evolution of shoulder prosthetics and the efficiency of the surgical process with the innovative tray system.
Read more →SIInterview with Dr. John Itamura
In an interview, Dr. John Itamura discusses his experiences with the InSet® Systems from Shoulder Innovations. He highlights the impressive biomechanics of the system and the rapid response of the company in addressing challenges. Dr. Itamura emphasizes the importance of the dedicated team behind the product, contributing to its success in shoulder arthroplasty.
Read more →SIShoulder Innovations Announces Securing of a $45M Debt Facility
Shoulder Innovations Inc. has secured a $45M debt facility with Trinity Capital, complementing its earlier $42M Series D equity financing. This funding aims to enhance the company's commercial and technological initiatives following the successful launch of its InSet® Shoulder Arthroplasty platform. The leadership expressed optimism about leveraging these resources for growth and innovation in shoulder replacement technology.
Read more →SIInterview with Dr. Ray Jensen
In an interview, Dr. Ray Jensen, an orthopedic surgeon, discusses his journey into orthopedics and his experience with the InSet® System from Shoulder Innovations. He highlights the system's mechanical advantages and ease of use, emphasizing its potential to improve patient outcomes in shoulder surgeries. Dr. Jensen also shares insights on effective surgical planning using PreView software.
Read more →Competitive Position
How SI ranks across every disease it competes inCompetitive Position is a premium feature
See how SI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial